INSULIN Act would expand insulin co-pay cap to commercial market and encourage competition. The Endocrine Society today endorsed the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act, a bipartisan bill to address insulin affordability introduced by Sens. Jeanne Shaheen (D-NH), Susan Collins (R-ME), Raphael Warnock (D-GA), and John Kennedy (R-LA). This historic legislation would cap out-of-pocket insulin costs at $35 per month for people on private insurance, protecting access to this life-saving medication for millions of people with diabetes. The legislation also would create a program to...
Martin O. Savage, Emeritus Professor of Pediatric Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, passed away on February 24, 2026. Martin Savage was a kind, generous, quietly spoken man, an inspirational pediatrician and an internationally renowned clinician scientist. He was passionate about teaching...
The Endocrine Society has selected five recipients for its Early Investigator Awards. The Early Investigators Awards were established to help develop early career investigators and recognize their accomplishments in endocrine-related research. Recipients will receive a $1,500 monetary award, complimentary registration and the opportunity to present at ENDO 2026, one year of free membership to the Society, and public recognition of research accomplishments in various Society platforms. ...
Endocrine Society member, Daniel Hochbaum, MD, has received a Pershing Square Foundation Award “MIND” Prize, which includes a $750,000, three year grant. Hochbaum, an assistant professor in the Program in Neuroscience at Harvard Medical School and Beth Israel Deaconess Medical Center. He is investigating how age-related declines in thyroid hormone signaling in the brain may...
Endocrine Society members elected Joy Wu, MD, PhD, of the Stanford University School of Medicine in Stanford, Calif., as its 2027 – 2028 President. She will serve as president-elect for a year beginning in June 2026 before becoming president in June 2027. Wu is the Gerald M. Reaven, MD Professor of Endocrinology, chief of the Division of Endocrinology and vice chair of basic...
Marcus D. Goncalves, MD, PhD, has been appointed director of the Holman Division of Endocrinology, Diabetes, and Metabolism at NYU Langone Health. He succeeds Ira J. Goldberg, MD, who has led the division since 2014 and will continue as a member of the faculty. Goncalves joined NYU Langone in 2024 from Weill Cornell Medicine and New York-Presbyterian Hospital....
The Endocrine Society is pleased to announce its Rare Endocrine Disease (RED) Fellows Program, a series designed to equip early-career physicians with the knowledge and practical skills needed to improve outcomes for people living with rare endocrine diseases. The program was developed in partnership with the National Organization for Rare Disorders (NORD) and addresses critical gaps in awareness, diagnosis and care of rare endocrine diseases. The program consists of two core components: The program accepts up...
The world of endocrinology – and indeed the world – lost a titan at the end of 2025 in Joel Habener, MD, who passed away December 28 at the age of 88. Habener, a professor of medicine at Harvard Medical School and director of the Laboratory of Molecular Endocrinology at Massachusetts General Hospital in Boston,...